Neuren PMS-301 Site#104 — Lexington, Massachusetts

Neuren PMS-301 Site#104 is a clinical research site located in Lexington, Massachusetts, United States 02421.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Neuren PMS-301 Site#104 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Phelan-McDermid Syndrome.

Sponsors: Neuren Pharmaceuticals Limited.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lexington

Browse all research sites in Massachusetts · View every site in Lexington

• Lurie Center for Autism, MassGeneral Hospital for Children
• Lurie Center Massachusetts General Hospital
• Lurie Center -MassGeneral Hospital
• Harvard University
• Massachusetts General Hospital
• Massachusetts General Hospital; Lurie Center for Autism
• Research Site
• Lurie Center for Autism
• Shire
• Lahey Clinic
• Inotek Pharmaceuticals Corporation
• Central Contact

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Neuren PMS-301 Site#104?

Neuren PMS-301 Site#104 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Neuren PMS-301 Site#104 conducted?

Neuren PMS-301 Site#104 has 1 clinical trials on record, with 1 currently active. Their work covers Phelan-McDermid Syndrome.

Is Neuren PMS-301 Site#104 accredited by Crixeo Clinical Trials?

Neuren PMS-301 Site#104 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Neuren PMS-301 Site#104?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.